Your search for comorbidities returned 920 results

Patients with sickle cell disease – especially those who have had silent cerebral infarcts or overt strokes – have cognitive impairment that results in reduced full-scale intelligence quotient scores.

Sinus tachycardia is the most commonly reported dysrhythmia in patients with COVID-19 disease.

Researchers conducted a systematic review and meta-analysis about the association of insomnia disorder characterized by objective sleep duration with hypertension, diabetes, and body mass index.

Appropriate treatment for hyperkalemia might be a key factor to improving renal outcome in patients with CKD, according to investigators.

The rates of venous thromboembolic events, including cerebral venous thrombosis, are increased among recipients of the Oxford-AstraZeneca vaccine ChAdOx1-S, although the absolute rates are small.

For health care personnel (HCP), the vaccine effectiveness (VE) of authorized mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna) against symptomatic COVID-19 illness is 82% and 94% for a single dose and for two doses.

A systematic review and meta-analysis was conducted to look at the effects of body mass index on atrial fibrillation‐related outcomes in anticoagulated patients.

Researchers investigate the potential prognostic predictor of TSB on COVID-19 mortality as well as the demographic and characteristics of this population.

Sodium-glucose cotransporter 2 inhibitors use may reduce cardiac arrhythmia risk, including the risk for atrial fibrillation.

Many US adults remain unprotected against vaccine-preventable diseases.